Clinical implications of a physiologic approach to paediatric high-frequency oscillatory ventilation
-
Published:2024-09-03
Issue:1
Volume:2
Page:
-
ISSN:2731-944X
-
Container-title:Intensive Care Medicine – Paediatric and Neonatal
-
language:en
-
Short-container-title:Intensive Care Med. Paediatr. Neonatal
Author:
de Jager Pauline, Markhorst Dick G., Cheifetz Ira M., Curley Martha A.Q., Kneyber Martin C.J.ORCID
Abstract
AbstractPaediatric acute respiratory distress syndrome (PARDS) is a manifestation of severe, life-threatening lung injury necessitating mechanical support. However, if inappropriately set and not tailored to the respiratory system mechanics of the individual patient, mechanical support of breathing can lead to ventilator-induced lung injury. High-frequency oscillatory ventilation (HFOV) is, at least theoretically, a justifiable mode to be considered to limit lung stress and strain, especially in patients severe PARDS. However, these theoretical benefits have not been translated into improved clinical outcomes. In addition, in adult ARDS HFOV is associated with harm. However, an important question is whether the results of the exisitng randomised clinical trials confirm that HFOV is not beneficial, and its use should be discouraged, or if it is a matter of how the oscillator was used that determins patient outcomes. Currently, HFOV is mainly used as a rescue mode of ventilation and titration of HFOV settings is mainly based on manufacturer’s recommendations, personal beliefs, and institutional preferences. We propose in this perspective a physiology-driven, open-lung strategy for paediatric HFOV for patients with moderate to severe lung disease to avoid injurious conventional ventilation settings, making use of lung recruitment manoeuvres, and setting high oscillatory frequencies to deliver the smallest distal pressure amplitudes. This approach has been shown feasible and safe in children, but needs evaluateion for efficacy. Future investigations should also explore HFOV weaning and monitoring during HFOV.
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Emeriaud G, Lopez-Fernandez YM, Iyer NP, Bembea MM, Agulnik A, Barbaro RP, Baudin F, Bhalla A, Brunow de Carvalho W, Carroll CL, Cheifetz IM, Chisti MJ, Cruces P, Curley MAQ, Dahmer MK, Dalton HJ, Erickson SJ, Essouri S, Fernandez A, Flori HR, Grunwell JR, Jouvet P, Killien EY, Kneyber MCJ, Kudchadkar SR, Korang SK, Lee JH, Macrae DJ, Maddux A, Modesto IAV, Morrow BM, Nadkarni VM, Napolitano N, Newth CJL, Pons-Odena M, Quasney MW, Rajapreyar P, Rambaud J, Randolph AG, Rimensberger P, Rowan CM, Sanchez-Pinto S, Ward S, Watson RS, Yehya N, Zimmerman JJ (2023) Khemani, RG, Second Pediatric Acute Lung Injury Consensus Conference Group on behalf of the Pediatric Acute Lung, I, Sepsis Investigators, N Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2). Pediatr Crit Care Med 24: 143–168 2. Tremblay LN, Slutsky AS (2006) Ventilator-induced lung injury: from the bench to the bedside. Intensive Care Med 32:24–33 3. Pinhu L, Whitehead T, Evans T, Griffiths M (2003) Ventilator-associated lung injury. Lancet 361:332–340 4. Goligher EC, Dres M, Patel BK, Sahetya SK, Beitler JR, Telias I, Yoshida T, Vaporidi K, Grieco DL, Schepens T, Grasselli G, Spadaro S, Dianti J, Amato M, Bellani G, Demoule A, Fan E, Ferguson ND, Georgopoulos D, Guerin C, Khemani RG, Laghi F, Mercat A, Mojoli F, Ottenheijm CAC, Jaber S, Heunks L, Mancebo J, Mauri T, Pesenti A, Brochard L (2020) Lung- and diaphragm-protective ventilation. Am J Respir Crit Care Med 202:950–961 5. Karageorgos V, Proklou A, Vaporidi K (2022) Lung and diaphragm protective ventilation: a synthesis of recent data. Expert Rev Respir Med 16:375–390
|
|